Multiple sclerosis: Biogen to settle claims it bribed doctors to prescribe drugs, with over $200m going to whistleblower - The BMJ
The drug company Biogen has agreed in principle to pay $900m (750m; 880m) to settle allegations it had bribed doctors to prescribe its multiple sclerosis drugs under the guise of paying them cons...
Read more